| +0.58 / +0.67%|
The 20 analysts offering 12-month price forecasts for Celgene Corp have a median target of 98.50, with a high estimate of 128.00 and a low estimate of 51.00. The median estimate represents a +12.26% increase from the last price of 87.74.
The current consensus among 25 polled investment analysts is to Buy stock in Celgene Corp. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.